Search

James H. Reamer

Examiner (ID: 10116)

Most Active Art Unit
1206
Art Unit(s)
1206, 1205, 1614, 3106, 2899, 2746
Total Applications
2884
Issued Applications
2358
Pending Applications
157
Abandoned Applications
369

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17982512 [patent_doc_number] => 20220348548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => Composition of 5-Fluorouracil and Refining Method Therefor [patent_app_type] => utility [patent_app_number] => 17/629777 [patent_app_country] => US [patent_app_date] => 2020-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4164 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629777 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/629777
Composition of 5-fluorouracil and refining method therefor Jan 9, 2020 Issued
Array ( [id] => 17905462 [patent_doc_number] => 11459305 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-04 [patent_title] => Processes for the preparation of uracil derivatives [patent_app_type] => utility [patent_app_number] => 16/739263 [patent_app_country] => US [patent_app_date] => 2020-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7210 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739263 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/739263
Processes for the preparation of uracil derivatives Jan 9, 2020 Issued
Array ( [id] => 15828473 [patent_doc_number] => 20200129518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINE MODULATORS OF GPR139 [patent_app_type] => utility [patent_app_number] => 16/732536 [patent_app_country] => US [patent_app_date] => 2020-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18823 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16732536 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/732536
4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139 Jan 1, 2020 Issued
Array ( [id] => 15831653 [patent_doc_number] => 20200131108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => METHOD FOR SYNTHESIZING NOVEL COMPOUNDS DERIVED FROM 3-HYDROXY-CYLOPENTYL ACETIC ACID [patent_app_type] => utility [patent_app_number] => 16/731705 [patent_app_country] => US [patent_app_date] => 2019-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10139 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 433 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16731705 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/731705
Method for synthesizing novel compounds derived from 3-hydroxy-cylopentyl acetic acid Dec 30, 2019 Issued
Array ( [id] => 15831835 [patent_doc_number] => 20200131199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => IMIDAZOOXAZOLE DERIVATIVE HAVING ANTITUMOR EFFECT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME [patent_app_type] => utility [patent_app_number] => 16/731277 [patent_app_country] => US [patent_app_date] => 2019-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8452 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16731277 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/731277
Imidazooxazole derivative having antitumor effect, and pharmaceutical composition including same Dec 30, 2019 Issued
Array ( [id] => 16504726 [patent_doc_number] => 20200383982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-10 [patent_title] => PHENYLOXADIAZOLE DERIVATIVES AS PGDS INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/724827 [patent_app_country] => US [patent_app_date] => 2019-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10722 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724827 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/724827
PHENYLOXADIAZOLE DERIVATIVES AS PGDS INHIBITORS Dec 22, 2019 Abandoned
Array ( [id] => 16443630 [patent_doc_number] => 10835534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-17 [patent_title] => Compounds [patent_app_type] => utility [patent_app_number] => 16/725709 [patent_app_country] => US [patent_app_date] => 2019-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18926 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16725709 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/725709
Compounds Dec 22, 2019 Issued
Array ( [id] => 18102365 [patent_doc_number] => 11542240 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-03 [patent_title] => STK19 inhibitors for treatment of cancer [patent_app_type] => utility [patent_app_number] => 16/722224 [patent_app_country] => US [patent_app_date] => 2019-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 112 [patent_no_of_words] => 41598 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16722224 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/722224
STK19 inhibitors for treatment of cancer Dec 19, 2019 Issued
Array ( [id] => 17634994 [patent_doc_number] => 11345707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-31 [patent_title] => Atropisomerism for increased kinase inhibitor selectivity [patent_app_type] => utility [patent_app_number] => 16/719379 [patent_app_country] => US [patent_app_date] => 2019-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 14786 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16719379 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/719379
Atropisomerism for increased kinase inhibitor selectivity Dec 17, 2019 Issued
Array ( [id] => 18289884 [patent_doc_number] => 11618746 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-04 [patent_title] => Inhibitors of APOL1 and methods of using same [patent_app_type] => utility [patent_app_number] => 16/717099 [patent_app_country] => US [patent_app_date] => 2019-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 79993 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16717099 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/717099
Inhibitors of APOL1 and methods of using same Dec 16, 2019 Issued
Array ( [id] => 18385605 [patent_doc_number] => 11656384 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-23 [patent_title] => Composition, film, lens, solid state imaging element, and compounds [patent_app_type] => utility [patent_app_number] => 16/713234 [patent_app_country] => US [patent_app_date] => 2019-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24472 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713234 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/713234
Composition, film, lens, solid state imaging element, and compounds Dec 12, 2019 Issued
Array ( [id] => 17922755 [patent_doc_number] => 11465988 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-11 [patent_title] => Process for the preparation of Tipiracil hydrochloride and intermediates thereof [patent_app_type] => utility [patent_app_number] => 17/418752 [patent_app_country] => US [patent_app_date] => 2019-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2869 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17418752 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/418752
Process for the preparation of Tipiracil hydrochloride and intermediates thereof Dec 12, 2019 Issued
Array ( [id] => 15866067 [patent_doc_number] => 20200140437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => QUINAZOLINE COMPOUND [patent_app_type] => utility [patent_app_number] => 16/712018 [patent_app_country] => US [patent_app_date] => 2019-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27692 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712018 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/712018
Quinazoline compound Dec 11, 2019 Issued
Array ( [id] => 15768659 [patent_doc_number] => 20200115347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-16 [patent_title] => DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 16/710373 [patent_app_country] => US [patent_app_date] => 2019-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35678 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16710373 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/710373
DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS Dec 10, 2019 Abandoned
Array ( [id] => 19456727 [patent_doc_number] => 12097195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-24 [patent_title] => Pharmaceutical composition containing alkynyl compound and preparation method and application thereof [patent_app_type] => utility [patent_app_number] => 17/259719 [patent_app_country] => US [patent_app_date] => 2019-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5938 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259719 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/259719
Pharmaceutical composition containing alkynyl compound and preparation method and application thereof Dec 8, 2019 Issued
Array ( [id] => 16321254 [patent_doc_number] => 10781210 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-22 [patent_title] => Nitrogen-containing heterocycle and carbocycle derivatives having TrkA inhibitory activity [patent_app_type] => utility [patent_app_number] => 16/684807 [patent_app_country] => US [patent_app_date] => 2019-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30112 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 939 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16684807 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/684807
Nitrogen-containing heterocycle and carbocycle derivatives having TrkA inhibitory activity Nov 14, 2019 Issued
Array ( [id] => 17335922 [patent_doc_number] => 20220002253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => METHOD FOR PRODUCING OROTIC ACID DERIVATIVE [patent_app_type] => utility [patent_app_number] => 17/291662 [patent_app_country] => US [patent_app_date] => 2019-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8719 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291662 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/291662
Method for producing orotic acid derivative Nov 6, 2019 Issued
Array ( [id] => 17421203 [patent_doc_number] => 11254644 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-22 [patent_title] => Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase [patent_app_type] => utility [patent_app_number] => 16/670676 [patent_app_country] => US [patent_app_date] => 2019-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 41735 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16670676 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/670676
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase Oct 30, 2019 Issued
Array ( [id] => 16253440 [patent_doc_number] => 20200262814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE [patent_app_type] => utility [patent_app_number] => 16/666108 [patent_app_country] => US [patent_app_date] => 2019-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32164 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16666108 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/666108
Protein kinase C inhibitors and methods of their use Oct 27, 2019 Issued
Array ( [id] => 15799983 [patent_doc_number] => 20200123134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-23 [patent_title] => PYRIDAZINONES AS PARP7 INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/662409 [patent_app_country] => US [patent_app_date] => 2019-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 145646 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16662409 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/662409
Pyridazinones as PARP7 inhibitors Oct 23, 2019 Issued
Menu